Display options
Cite
Petrov MK, Dimitrova M, Petrova GI. COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS. Value Health. 2014;17(7):A470doi: 10.1016/j.jval.2014.08.1332.
Petrov, M. K., Dimitrova, M., & Petrova, G. I. (2014). COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A470. https://doi.org/10.1016/j.jval.2014.08.1332
Petrov, M K, et al. "COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A470. doi: https://doi.org/10.1016/j.jval.2014.08.1332
Petrov MK, Dimitrova M, Petrova GI. COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS. Value Health. 2014 Nov;17(7):A470. doi: 10.1016/j.jval.2014.08.1332. Epub 2014 Oct 26. PMID: 27201344.
Copy Download .nbib Format: NLM
Share it on

Value Health. 2014 Nov;17(7):A470. doi: 10.1016/j.jval.2014.08.1332. Epub 2014 Oct 26.

COST- MINIMIZATION ANALYSIS OF THE DIRECT COSTS OF SEVELAMER CARBONATE AND LANTHANUM CARBONATE IN THE TREATMENT OF CKD-ND PATIENTS.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

M K Petrov, M Dimitrova, G I Petrova

Affiliations

  1. Sanofi Bulgaria, Sofia, Bulgaria.
  2. Medical University of Sofia, Faculty of Pharmacy, Sofia, Bulgaria.
  3. Medical University, Faculty of Pharmacy, Sofia, Bulgaria.

PMID: 27201344 DOI: 10.1016/j.jval.2014.08.1332

[No abstract available.]

Publication Types